• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

II 型 p21 激活激酶(PAKs)受自身抑制性假底物调节。

Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.

机构信息

Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16107-12. doi: 10.1073/pnas.1214447109. Epub 2012 Sep 17.

DOI:10.1073/pnas.1214447109
PMID:22988085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3479536/
Abstract

The type II p21-activated kinases (PAKs) are key effectors of RHO-family GTPases involved in cell motility, survival, and proliferation. Using a structure-guided approach, we discovered that type II PAKs are regulated by an N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline residue, and that this regulation occurs independently of activation loop phosphorylation. We determined six X-ray crystal structures of either full-length PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudosubstrate binding to the active state with phosphorylated activation loop. We show that full-length PAK4 is constitutively autoinhibited, but mutation of the pseudosubstrate releases this inhibition and causes increased phosphorylation of the apoptotic regulation protein Bcl-2/Bcl-X(L) antagonist causing cell death and cellular morphological changes. We also find that PAK6 is regulated by the pseudosubstrate region, indicating a common type II PAK autoregulatory mechanism. Finally, we find Src SH3, but not β-PIX SH3, can activate PAK4. We provide a unique understanding for type II PAK regulation.

摘要

II 型 p21 激活激酶(PAKs)是 RHO 家族 GTPases 的关键效应物,参与细胞运动、存活和增殖。我们采用结构导向方法发现,II 型 PAK 受到以关键脯氨酸残基为中心的 N 端自动抑制假底物基序调控,这种调控独立于激活环磷酸化。我们测定了全长 PAK4 或其催化结构域的六个 X 射线晶体结构,证明了假底物与磷酸化激活环的活性状态结合的分子基础。我们表明全长 PAK4 是组成性自动抑制的,但假底物的突变会解除这种抑制,导致凋亡调节蛋白 Bcl-2/Bcl-X(L)拮抗剂的磷酸化增加,从而导致细胞死亡和细胞形态变化。我们还发现 PAK6 受假底物区域调控,表明存在共同的 II 型 PAK 自我调控机制。最后,我们发现 Src SH3,但不是 β-PIX SH3,可以激活 PAK4。我们为 II 型 PAK 调控提供了独特的理解。

相似文献

1
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.II 型 p21 激活激酶(PAKs)受自身抑制性假底物调节。
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16107-12. doi: 10.1073/pnas.1214447109. Epub 2012 Sep 17.
2
Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6.Ⅱ型 p21 激活激酶 PAK6 的底物和抑制剂特异性。
PLoS One. 2013 Oct 28;8(10):e77818. doi: 10.1371/journal.pone.0077818. eCollection 2013.
3
Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.II型p21激活激酶的信号传导、调控及特异性
J Biol Chem. 2015 May 22;290(21):12975-83. doi: 10.1074/jbc.R115.650416. Epub 2015 Apr 8.
4
Rho family GTPase signaling through type II p21-activated kinases.Rho 家族 GTP 酶信号转导通过 II 型 p21 激活激酶。
Cell Mol Life Sci. 2022 Nov 19;79(12):598. doi: 10.1007/s00018-022-04618-2.
5
Group I and II mammalian PAKs have different modes of activation by Cdc42.I 类和 II 类哺乳动物 PAK 被 Cdc42 以不同的模式激活。
EMBO Rep. 2012 Jun 29;13(7):653-9. doi: 10.1038/embor.2012.75.
6
Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.与来自PAK2的高亲和力肽结合的βPIX的SH3结构域的晶体结构。
J Mol Biol. 2006 Apr 28;358(2):509-22. doi: 10.1016/j.jmb.2006.02.027. Epub 2006 Feb 28.
7
CDC42 binds PAK4 via an extended GTPase-effector interface.CDC42 通过扩展的 GTPase 效应器界面结合 PAK4。
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):531-536. doi: 10.1073/pnas.1717437115. Epub 2018 Jan 2.
8
NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different from that of PAK1.NMR 结合和晶体结构揭示,固有无序的调节结构域通过一种与 PAK1 不同的机制来自动抑制 PAK4。
Biochem Biophys Res Commun. 2013 Aug 16;438(1):169-74. doi: 10.1016/j.bbrc.2013.07.047. Epub 2013 Jul 20.
9
Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase.丝裂原活化蛋白激酶激酶6和p38丝裂原活化蛋白激酶对p21活化激酶6的激活作用。
J Biol Chem. 2005 Feb 4;280(5):3323-30. doi: 10.1074/jbc.M406701200. Epub 2004 Nov 18.
10
The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.I 型 p21 激活激酶的亚细胞定位由无序可变区和多碱性序列控制。
J Biol Chem. 2019 Sep 27;294(39):14319-14332. doi: 10.1074/jbc.RA119.007692. Epub 2019 Aug 7.

引用本文的文献

1
P21 activated kinase 6: a promising tool for predicting small cell lung cancer diagnosis and treatment response.P21激活激酶6:预测小细胞肺癌诊断和治疗反应的一种有前景的工具。
PeerJ. 2025 Jul 21;13:e19714. doi: 10.7717/peerj.19714. eCollection 2025.
2
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner.PAK6 以突变特异性的方式挽救致病性 LRRK2 介导的纤毛发生和中心体粘连缺陷。
Cell Death Dis. 2024 Oct 17;15(10):752. doi: 10.1038/s41419-024-07124-4.
3
P-21 Activated Kinases in Liver Disorders.肝脏疾病中的P-21激活激酶
Cancers (Basel). 2023 Jan 16;15(2):551. doi: 10.3390/cancers15020551.
4
Rho family GTPase signaling through type II p21-activated kinases.Rho 家族 GTP 酶信号转导通过 II 型 p21 激活激酶。
Cell Mol Life Sci. 2022 Nov 19;79(12):598. doi: 10.1007/s00018-022-04618-2.
5
Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4).整合素黏附受体与 p21 激活激酶 4(PAK4)结合的分子基础。
Commun Biol. 2022 Nov 17;5(1):1257. doi: 10.1038/s42003-022-04157-3.
6
p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.p21激活激酶:在胃肠道癌及其他方面的作用
Cancers (Basel). 2022 Sep 28;14(19):4736. doi: 10.3390/cancers14194736.
7
Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents.p21激活激酶4抑制剂作为抗肿瘤药物的研发新进展。
Front Pharmacol. 2022 Aug 29;13:956220. doi: 10.3389/fphar.2022.956220. eCollection 2022.
8
The significance of PAK4 in signaling and clinicopathology: A review.PAK4在信号传导和临床病理学中的意义:综述
Open Life Sci. 2022 Jun 20;17(1):586-598. doi: 10.1515/biol-2022-0064. eCollection 2022.
9
The role of cell division control protein 42 in tumor and non-tumor diseases: A systematic review.细胞分裂控制蛋白42在肿瘤和非肿瘤疾病中的作用:一项系统综述。
J Cancer. 2022 Jan 1;13(3):800-814. doi: 10.7150/jca.65415. eCollection 2022.
10
p21-Activated kinases as promising therapeutic targets in hematological malignancies.p21-激活的激酶作为血液系统恶性肿瘤有前途的治疗靶点。
Leukemia. 2022 Feb;36(2):315-326. doi: 10.1038/s41375-021-01451-7. Epub 2021 Oct 25.

本文引用的文献

1
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.外显子组测序鉴定黑色素瘤中复发性体细胞 RAC1 突变。
Nat Genet. 2012 Sep;44(9):1006-14. doi: 10.1038/ng.2359. Epub 2012 Jul 29.
2
Group I and II mammalian PAKs have different modes of activation by Cdc42.I 类和 II 类哺乳动物 PAK 被 Cdc42 以不同的模式激活。
EMBO Rep. 2012 Jun 29;13(7):653-9. doi: 10.1038/embor.2012.75.
3
Structural insights into the autoactivation mechanism of p21-activated protein kinase.结构洞察 p21 激活蛋白激酶的自动激活机制。
Structure. 2011 Dec 7;19(12):1752-61. doi: 10.1016/j.str.2011.10.013.
4
Exome sequencing identifies GRIN2A as frequently mutated in melanoma.外显子组测序鉴定出 GRIN2A 在黑色素瘤中经常发生突变。
Nat Genet. 2011 May;43(5):442-6. doi: 10.1038/ng.810. Epub 2011 Apr 15.
5
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.p21 激活激酶 4 调节卵巢癌细胞增殖、迁移和侵袭,并导致患者预后不良。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18622-7. doi: 10.1073/pnas.0907481107. Epub 2010 Oct 6.
6
Diverse somatic mutation patterns and pathway alterations in human cancers.人类癌症中的多种体细胞突变模式和通路改变。
Nature. 2010 Aug 12;466(7308):869-73. doi: 10.1038/nature09208. Epub 2010 Jul 28.
7
N-terminal interaction domain implicates PAK4 in translational regulation and reveals novel cellular localization signals.N 端相互作用结构域牵涉 PAK4 参与翻译调控并揭示新的细胞定位信号。
J Cell Physiol. 2010 Sep;224(3):722-33. doi: 10.1002/jcp.22172.
8
p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration.p21 激活激酶 4 对整合素 β5 丝氨酸 759 和丝氨酸 762 的磷酸化调节细胞迁移。
J Biol Chem. 2010 Jul 30;285(31):23699-710. doi: 10.1074/jbc.M110.123497. Epub 2010 May 27.
9
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.小分子 p21 激活激酶抑制剂 PF-3758309 是一种有效的致癌信号和肿瘤生长抑制剂。
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9446-51. doi: 10.1073/pnas.0911863107. Epub 2010 May 3.
10
PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.PAK4:一种多能激酶,可调节前列腺癌细胞黏附。
J Cell Sci. 2010 May 15;123(Pt 10):1663-73. doi: 10.1242/jcs.055707. Epub 2010 Apr 20.